O	0	1	A
O	2	13	Prospective
O	13	14	,
O	15	25	Randomized
O	25	26	,
O	27	37	Controlled
O	38	43	Trial
O	44	46	of
B-intervention	47	60	Paravertebral
I-intervention	61	66	Block
O	67	73	versus
B-control	74	81	General
I-control	82	92	Anesthesia
I-control	93	98	Alone
O	99	102	for
O	103	113	Prosthetic
O	114	120	Breast
O	121	135	Reconstruction
O	135	136	.

O	137	150	Paravertebral
O	151	157	blocks
O	158	162	have
O	163	169	gained
O	170	180	popularity
O	181	188	because
O	189	191	of
O	192	196	ease
O	197	199	of
O	200	214	implementation
O	215	218	and
O	219	220	a
O	221	226	shift
O	227	233	toward
O	234	244	ambulatory
O	245	251	breast
O	252	259	surgery
O	260	270	procedures
O	270	271	.

O	272	280	Previous
O	281	294	retrospective
O	295	302	studies
O	303	307	have
O	308	316	reported
O	317	326	potential
O	327	335	benefits
O	336	338	of
O	339	352	paravertebral
O	353	359	blocks
O	359	360	,
O	361	370	including
O	371	380	decreased
O	381	389	narcotic
O	390	393	and
O	394	404	antiemetic
O	405	408	use
O	408	409	.

O	410	413	The
O	414	421	authors
O	422	431	conducted
O	432	433	a
O	434	445	prospective
O	446	456	controlled
O	457	462	trial
O	463	465	of
B-eligibility	466	474	patients
I-eligibility	475	485	undergoing
I-eligibility	486	492	breast
I-eligibility	493	507	reconstruction
O	508	512	over
O	513	514	a
O	515	516	3
O	516	517	-
O	517	521	year
O	522	528	period
O	528	529	.

O	530	533	The
O	534	542	patients
O	543	547	were
O	548	558	randomized
O	559	561	to
O	562	568	either
O	569	570	a
O	571	576	study
O	577	582	group
O	583	585	of
O	586	599	paravertebral
O	600	606	blocks
O	607	611	with
O	612	619	general
O	620	630	anesthesia
O	631	633	or
O	634	635	a
O	636	643	control
O	644	649	group
O	650	652	of
O	653	660	general
O	661	671	anesthesia
O	672	677	alone
O	677	678	.

O	679	690	Demographic
O	691	694	and
O	695	705	procedural
O	706	710	data
O	710	711	,
O	712	714	in
O	715	723	addition
O	724	726	to
O	727	731	data
O	732	741	regarding
O	742	746	pain
O	747	750	and
O	751	757	nausea
O	758	765	patient
O	765	766	-
O	766	774	reported
O	775	782	numeric
O	783	789	scores
O	790	793	and
O	794	805	consumption
O	806	808	of
O	809	815	opioid
O	816	819	and
O	820	830	antiemetic
O	831	842	medications
O	842	843	,
O	844	848	were
O	849	857	recorded
O	857	858	.

O	859	860	A
O	861	866	total
O	867	869	of
B-total-participants	870	872	74
O	873	881	patients
O	882	886	were
O	887	895	enrolled
O	896	898	to
O	899	905	either
O	906	909	the
O	910	923	paravertebral
O	924	929	block
O	930	931	(
O	931	932	n
O	933	934	=
B-intervention-participants	935	937	35
O	937	938	)
O	939	941	or
O	942	945	the
O	946	953	control
O	954	959	group
O	960	961	(
O	961	962	n
O	963	964	=
B-control-participants	965	967	39
O	967	968	)
O	968	969	.

O	970	975	There
O	976	980	were
O	981	983	no
O	984	995	significant
O	996	1007	differences
O	1008	1010	in
O	1011	1014	age
O	1014	1015	,
O	1016	1020	body
O	1021	1025	mass
O	1026	1031	index
O	1031	1032	,
O	1033	1042	procedure
O	1043	1047	type
O	1047	1048	,
O	1049	1051	or
O	1052	1058	cancer
O	1059	1068	diagnosis
O	1069	1076	between
O	1077	1080	the
O	1081	1084	two
O	1085	1091	groups
O	1091	1092	.

O	1093	1101	Patients
O	1102	1105	who
O	1106	1114	received
O	1115	1116	a
O	1117	1130	paravertebral
O	1131	1136	block
O	1137	1145	required
O	1146	1150	less
B-outcome	1151	1157	opioid
I-outcome	1158	1174	intraoperatively
I-outcome	1175	1178	and
I-outcome	1179	1194	postoperatively
O	1195	1203	combined
O	1204	1212	compared
O	1213	1217	with
O	1218	1226	patients
O	1227	1230	who
O	1231	1234	did
O	1235	1238	not
O	1239	1246	receive
O	1247	1260	paravertebral
O	1261	1267	blocks
O	1268	1269	(
B-iv-cont-mean	1269	1272	109
O	1273	1279	versus
B-cv-cont-mean	1280	1283	246
I-cv-cont-mean	1284	1292	fentanyl
I-cv-cont-mean	1293	1303	equivalent
I-cv-cont-mean	1304	1309	units
O	1309	1310	;
O	1311	1312	p
O	1313	1314	<
O	1315	1316	0
O	1316	1317	.
O	1317	1320	001
O	1320	1321	)
O	1321	1322	,
O	1323	1326	and
O	1327	1335	reported
O	1336	1349	significantly
O	1350	1355	lower
B-outcome	1356	1360	pain
I-outcome	1361	1367	scores
I-outcome	1368	1370	at
I-outcome	1371	1372	0
I-outcome	1373	1375	to
I-outcome	1376	1377	1
O	1378	1379	(
B-iv-cont-mean	1379	1380	3
I-iv-cont-mean	1380	1381	.
I-iv-cont-mean	1381	1382	0
O	1383	1389	versus
B-cv-cont-mean	1390	1391	4
I-cv-cont-mean	1391	1392	.
I-cv-cont-mean	1392	1393	6
O	1393	1394	;
O	1395	1396	p
O	1397	1398	=
O	1399	1400	0
O	1400	1401	.
O	1401	1403	02
O	1403	1404	)
O	1404	1405	,
B-outcome	1406	1407	1
I-outcome	1408	1410	to
I-outcome	1411	1412	3
O	1413	1414	(
B-iv-cont-mean	1414	1415	2
I-iv-cont-mean	1415	1416	.
I-iv-cont-mean	1416	1417	0
O	1418	1424	versus
B-cv-cont-mean	1425	1426	3
I-cv-cont-mean	1426	1427	.
I-cv-cont-mean	1427	1428	2
O	1428	1429	;
O	1430	1431	p
O	1432	1433	=
O	1434	1435	0
O	1435	1436	.
O	1436	1438	01
O	1438	1439	)
O	1439	1440	,
O	1441	1444	and
B-outcome	1445	1446	3
I-outcome	1447	1449	to
I-outcome	1450	1451	6
O	1452	1453	(
B-iv-cont-mean	1453	1454	1
I-iv-cont-mean	1454	1455	.
I-iv-cont-mean	1455	1456	9
O	1457	1463	versus
B-cv-cont-mean	1464	1465	2
I-cv-cont-mean	1465	1466	.
I-cv-cont-mean	1466	1467	7
O	1467	1468	;
O	1469	1470	p
O	1471	1472	=
O	1473	1474	0
O	1474	1475	.
O	1475	1477	04
O	1477	1478	)
O	1479	1484	hours
O	1485	1500	postoperatively
O	1500	1501	.

O	1502	1505	The
O	1506	1511	study
O	1512	1517	group
O	1518	1522	also
O	1523	1531	consumed
O	1532	1536	less
B-outcome	1537	1547	antiemetic
I-outcome	1548	1558	medication
O	1559	1560	(
B-iv-cont-mean	1560	1561	0
I-iv-cont-mean	1561	1562	.
I-iv-cont-mean	1562	1563	7
O	1564	1570	versus
B-cv-cont-mean	1571	1572	2
I-cv-cont-mean	1572	1573	.
I-cv-cont-mean	1573	1574	1
O	1574	1575	;
O	1576	1577	p
O	1578	1579	=
O	1580	1581	0
O	1581	1582	.
O	1582	1584	05
O	1584	1585	)
O	1585	1586	.

O	1587	1600	Incorporating
O	1601	1614	paravertebral
O	1615	1621	blocks
O	1622	1629	carries
O	1630	1642	considerable
O	1643	1652	potential
O	1653	1656	for
O	1657	1666	improving
O	1667	1675	pathways
O	1676	1679	for
O	1680	1686	breast
O	1687	1693	cancer
O	1694	1702	patients
O	1703	1713	undergoing
O	1714	1720	breast
O	1721	1735	reconstruction
O	1735	1736	-
O	1736	1737	-
O	1737	1741	with
O	1742	1749	minimal
O	1750	1759	procedure
O	1759	1760	-
O	1760	1767	related
O	1768	1777	morbidity
O	1777	1778	.

O	1779	1783	This
O	1784	1786	is
O	1787	1790	the
O	1791	1796	first
O	1797	1808	prospective
O	1809	1814	study
O	1815	1823	designed
O	1824	1826	to
O	1827	1833	assess
O	1834	1847	paravertebral
O	1848	1854	blocks
O	1855	1857	in
O	1858	1861	the
O	1862	1869	setting
O	1870	1872	of
O	1873	1883	prosthetic
O	1884	1890	breast
O	1891	1905	reconstruction
O	1905	1906	.

O	1907	1918	Therapeutic
O	1918	1919	,
O	1920	1922	II
O	1922	1923	.
